https://www.fiercebiotech.com/biotech/retrophin-buys-up-orphan-technologies-spending-90m-rare-disease-drug
Retrophin has snapped up Orphan Technologies for a $90 million upfront payment, gaining access to the biotech's rare metabolic disorder drug OT-58.
rare diseaseretrophinbuysorphantechnologies